The US FDA's drugs and biologics centers increasingly follow different regulatory routes as the agency accommodates the growing regenerative medicine pipeline. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
